Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Sun, Jie  [Clear All Filters]
2024
Liu P, Bai K, Zhang Z, Sun J. Analysis of early clinical signs and risk factors for severe hemorrhagic cystitis after stem cell transplantation in children. Int J Urol. 2024.
Zhang L-C, Li N, Chen J-L, Sun J, Xu M, Liu W-Q, Zuo Z-F, Shi L-L, Wang T-H, Luo X-Y. Molecular network mechanism in cerebral ischemia-reperfusion rats treated with human urine stem cells. Heliyon. 2024;10(7):e27508.
Jiang B, Zhao Y, Luo Y, Yu J, Chen Y, Ye B, Fu H, Lai X, Liu L, Ye Y, et al. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring Rearrangement and Its Prognostic Factors. Cell Transplant. 2024;33:9636897231225821.
2023
Cai B, Song W, Chen S, Sun J, Zhou R, Han Z, Wan J. Bone Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Lipopolysaccharide-Induced Lung Injury Via the miR-21-5p/PCSK6 Pathway. J Immunol Res. 2023;2023:3291137.
Liao C, Wang Y, Huang Y, Duan Y, Liang Y, Chen J, Jiang J, Shang K, Zhou C, Gu Y, et al. CD38-Specific CAR Integrated into CD38 Locus Driven by Different Promoters Causes Distinct Antitumor Activities of T and NK Cells. Adv Sci (Weinh). 2023:e2207394.
Yang T, Jiang B, Luo Y, Zhao Y, Ouyang G, Yu J, Lan J, Lu Y, Lai X, Ye B, et al. Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms. Am J Hematol. 2023.
Huang F, Sun J, Chen W, Zhang L, He X, Dong H, Wu Y, Wang H, Li Z, Ball B, et al. Correction: TET2 deficiency promotes MDS-associated leukemogenesis. Blood Cancer J. 2023;13(1):174.
Sun J, Zhang X, Fu C, Ahmad N, Zhao C, Hou L, Naeem M, Pan J, Wang X, Zhao S. Genome-wide identification and expression analysis of GA20ox and GA3ox genes during pod development in peanut. PeerJ. 2023;11:e16279.
Jiang J, Chen J, Liao C, Duan Y, Wang Y, Shang K, Huang Y, Tang Y, Gao X, Gu Y, et al. Inserting EF1α-driven CD7-specific CAR at CD7 locus reduces fratricide and enhances tumor rejection. Leukemia. 2023.
Xiao J, Han Q, Yu Z, Liu M, Sun J, Wu M, Yin H, Fu J, Guo Y, Wang L, et al. Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway. Pharmaceuticals (Basel). 2023;16(10).
Yuan X-L, Lai X-Y, Wu Y-B, Yang L-X, Shi J-M, Liu L-Z, Yu J, Zhao Y-M, Zheng W-Y, He J-S, et al. A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation. Bone Marrow Transplant. 2023.
Yang X, Zheng M, Ning Y, Sun J, Yu Y, Zhang S. Prognostic risk factors of serous ovarian carcinoma based on mesenchymal stem cell phenotype and guidance for therapeutic efficacy. J Transl Med. 2023;21(1):456.
2022
Zhao H, Lu J, Yan T, Han F, Sun J, Yin X, Chen L, Shen C, Wunderlich M, Yun W, et al. Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2. Cell Rep. 2022;38(4):110253.
Wang H, Mao L, Yang M, Qian P, Lu H, Tong H, Xie W, Zhou D, Huang X, Wang Y, et al. Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial. Lancet Haematol. 2022.
2021
Jing R, Jiao P, Chen J, Meng X, Wu X, Duan Y, Shang K, Qian L, Huang Y, Liu J, et al. Cas9-Cleavage Sequences in Size-Reduced Plasmids Enhance Nonviral Genome Targeting of CARs in Primary Human T Cells. Small Methods. 2021;5(7):e2100071.
Yun L, Wang L, Pan Y, Liu M, Han Q, Sun J, Yang G, Xiao J, Guo Y, Ma Y. Current status and development trend of miRNAs in osteoporosis-related research: A bibliometric analysis. Folia Histochem Cytobiol. 2021.
2020
Huang F, Sun J, Chen W, He X, Zhu Y, Dong H, Wang H, Li Z, Zhang L, Khaled S, et al. HDAC4 inhibition disrupts TET2 function in high-risk MDS and AML. Aging (Albany NY). 2020;12.
Wu W, Zhou Q, Masubuchi T, Shi X, Li H, Xu X, Huang M, Meng L, He X, Zhu H, et al. Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy. Cell. 2020.
Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, Deng X, Li H, Huang Y, Gao L, et al. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion. Cancer Cell. 2020.
2019
Ye P, Pei R, Jin J, Sun J, Li K, Cao J, Zhou D, Lu Y. Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2019.
2018
Li X, Fan C, Xiao Z, Zhao Y, Zhang H, Sun J, Zhuang Y, Wu X, Shi J, Chen Y, et al. A collagen microchannel scaffold carrying paclitaxel-liposomes induces neuronal differentiation of neural stem cells through Wnt/β-catenin signaling for spinal cord injury repair. Biomaterials. 2018;183:114-127.
Zhong L, Ju G-Q, Liu G-H, Sun J. [Mechanisms of stem cell-derived extracellular vesicles protecting Leydig cells from acute oxidative injury in rats]. Zhonghua Nan Ke Xue. 2018;24(1):14-18.
2016
Li X, Li M, Sun J, Zhuang Y, Shi J, Guan D, Chen Y, Dai J. Radially Aligned Electrospun Fibers with Continuous Gradient of SDF1α for the Guidance of Neural Stem Cells. Small. 2016.
2015
Sun J, Shen Q, Lu H, Jiang Z, Xu W, Feng L, Li L, Wang X, Cai X, Jin H. Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance. Oncotarget. 2015.
Qin W, Li X, Peng Y, Harlow LM, Ren Y, Wu Y, Li J, Qin Y, Sun J, Brown T, et al. Sclerostin Antibody Preserves the Morphology and Structure of Osteocytes and Blocks the Severe Skeletal Deterioration after Motor-Complete Spinal Cord Injury in Rats. J Bone Miner Res. 2015.

Pages